\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={The Knowledge, Attitude and Practice of Taking Covid-19 Vaccination among the Rural and Urban People in Patuakhali District},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{2021-07-15 (revised: 15 July 2021)}
\def\TheID{\makeatother }
\def\TheDate{2021-07-15}
\title{The Knowledge, Attitude and Practice of Taking Covid-19 Vaccination among the Rural and Urban People in Patuakhali District}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{Sultan Ahmed  Sikder}

             \author[2]{Sharmin Jahan  Shubarna}

             \author[3]{Sahedul Islam  Bhuiyan}

             \author[4]{Mohoshina  Karim}

\renewcommand\Authands{ and }

\date{\small \em Received: 5 June 2021 Accepted: 2 July 2021 Published: 15 July 2021}

\maketitle


\begin{abstract}
        


Objective: In this study our main goal is to evaluate the Knowledge, Attitude and Practice of taking Covid-19 vaccination among the rural and urban people in Patuakhali District. Method: This cross-sectional study was carried out at Tertiary medical College Hospital, Patuakhali District. Bangladesh. Where data were collected from July 2020 to May 2021. A total of 120 participants where in rural 60 participants and in urban 60 participants were included in the study. Results: During the study, in rural group majority of cases belong to 32-43 years age group, 38.3% where as in urban group 51.7% were belong to 44-54 years age group. In both group majority of the cases were HSC passed, 50% and 55%. In urban group most cases had proper knowledge about covid-19 vaccination.

\end{abstract}


\keywords{Covid-19, vaccine, KAP study.}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\let\tabcellsep& 	 	 		 
\section[{Introduction}]{Introduction}\par
s SARS-CoV-2 is highly infectious virus that impacts communities around the globe, vaccines are the most significant measure of public health and the most effective approach for protecting the population against COVID-19. The competitive effort for the discovery and development of COVID-19 vaccines against the spread and disastrous consequences of the illness is ongoing with the creation of new, more effective vaccinations as the pandemic passes. \hyperref[b0]{[1]}\hyperref[b1]{[2]} The distribution of vaccines is in the process and the acceptance of COVID-19 immunizations by the community must be investigated. \hyperref[b2]{3} On 27 January 2021 the Bangladeshi authorities decided to utilize the Indian vaccination Covidshield; Runu (A Nurse) was the first COVID-19 receiver. \hyperref[b3]{4} Bangladeshi officials approved. However, there is a large debate among the general people of Bangladesh over COVID-19 vaccines. A fraction of the people of Bangladesh hesitate to take the Indian vaccination so that they are not infected. \hyperref[b4]{5} A worldwide COVID-19 research showed that 48 percent of the study population had misunderstandings with the COVID-19 vaccines and were doubtful about their vaccination. \hyperref[b5]{6} In this study our main goal is to evaluate the Knowledge, Attitude and Practice of taking Covid-19 vaccination among the rural and urban people in Patuakhali District. 
\section[{II.}]{II.} 
\section[{Objective}]{Objective}\par
? To assess the Knowledge, Attitude and Practice of taking Covid-19 vaccination among the rural and urban people. 
\section[{III.}]{III.}\par
Methodology a) Types of study In rural area highest 30 (50\%) respondents were HSC passed followed by primary 13 (21.7\%) and in urban area highest 25 (41.25\%) respondents were HSC followed by graduate 18 (30\%). The association of Covid-19 infected status between rural \& urban respondents were highly significant (P= 0.00), similarly knowledge regarding first vaccine in Bangladesh also highly significant (p=0.02) between rural \& urban respondents. Another findings regarding knowledge related factor regarding the lowest age range for this vaccination was moderately significant (p=0.03), finally knowledge related factor regarding the way to take the vaccine was also significantly associated (p=0.04) between the respondents of rural \& urban area, beside the knowledge related factors the other variables were not significantly associated. The association of Covid-19 vaccine taken status between rural \& urban respondents were highly significant (P= 0.00), similarly the opinion regarding so many rumors about corona vaccine also moderately significant (p=0.03) others attitude and practice related factors were not significantly associated. 
\section[{c) Study population}]{c) Study population}\par
? A total of 120 participants where in rural 60 participants and in urban 60 participants were included in the study. Sample were collected through purposive sampling as per inclusion criteria. 
\section[{d) Method}]{d) Method}\par
? Data were collected by using a pre designed questionnaire. The questionnaire was prepared reviewing literature and consulting with medical research experts. 
\section[{e) Data analysis}]{e) Data analysis}\par
? All collected data were coding and input in SPSS-25 for further analysis. Both descriptive and inferential statistics done. Descriptive statistics included frequency distribution, percent, mean, standard deviation; graph, tables, figures and inferential statistics.\par
IV. 
\section[{Results}]{Results}\par
In figure-1 shows gender distribution of the study group where in both group majority of the cases were male. The following figure is given below in detail:  It was found from the table no. 2 that in rural area highest 30 (50\%) respondents were HSC passed followed by primary 13 (21.7\%) and in urban area highest 25 (41.25\%) respondents were HSC followed by graduate 18 (30\%). The bellow table is given in details. V. 
\section[{Discussion}]{Discussion}\par
During the study, knowledge was significantly associated with education, monthly income of a family, and previous vaccine uptake experience. However, attitudes were significantly associated with only gender and earlier vaccine administration experience. Importantly, the majority of participants showed positive attitude towards COVID-19 vaccine.\par
Knowledge regarding COVID-19 vaccinations negative correlation observed in terms of participants' gender. This finding is similar to studies concerning knowledge towards COVID-19 (not vaccinations) conducted in Bangladesh which reported that males had marginally higher scores in knowledge regarding COVID-19 than females. \hyperref[b6]{7} However, this finding is inconsistent to studies concerning knowledge towards COVID-19 (not vaccinations) conducted in Bangladesh which reported that males had marginally higher scores in knowledge regarding COVID-19 than females. \hyperref[b7]{8} These discrepancies of knowledge found in our study on COVID-19 vaccinations are possibly due to limited government exposures to information or publicity on COVID-19 vaccinations since the vaccine rollout started. In addition, the potential under-reporting or misinformation of data on the seriousness of incidence and mortality of COVID-19 may reduce concerns about vaccine safety or indeed make residents of Bangladesh reluctant to seek information on either COVID-19 or related vaccinations. Thus, it is essential to support community members by providing easy access to trusted, evidence-based vaccine information. \hyperref[b8]{9} According to our study, participants with a higher level of education were found to have more knowledge about COVID-19 vaccinations, which is also supported by previous research. Similar scenarios were found in other earlier studies in Bangladesh, illustrating that individuals with a higher educational background showed more knowledge regarding COVID-19. \hyperref[b9]{10} It may be the case that more educated people are more knowledgeable and concerned about their health and well-being, through access to more information sources, and become more engaged in life events that could impact them, such as COVID-19 vaccinations. \hyperref[b10]{11} People who have received any vaccine earlier were found to have more knowledge regarding COVID-19 vaccinations in this study. A recent study in China evaluating COVID-19 vaccine acceptance found that people who were previously vaccinated against influenza were more likely to accept the COVID-19 vaccine, which was also demonstrated in a study in Hong Kong. \hyperref[b11]{12,}\hyperref[b2]{3} This tendency among people may be due to previous positive experiences from vaccination. The level of knowledge about COVID-19 vaccinations were significantly higher among people living in the urban areas, compared to rural areas. This is supported by an earlier study in Bangladesh which demonstrated significant correlation between COVID-19 knowledge and urban location. \hyperref[b6]{7} However, our finding is inconsistent with a recent study which found more accurate knowledge about COVID-19 among people in rural areas in Bangladesh. \hyperref[b7]{8} In the present study, over 80\% of participants had more positive attitudes towards COVID-19 vaccine. This association is in line with a previous study on attitudes towards dengue vaccination conducted in Indonesia [35] and attitudes towards COVID-19 carried out in Bangladesh. \hyperref[b7]{8} In our study, in participants assumed that the recently discovered COVID-19 vaccine (the vaccine currently being used in Bangladesh) could have some side-effect, which is similar to a study in the US. \hyperref[b12]{13} A study in China found that 48\% of respondents postponed vaccination before confirmation of the safety of the vaccine, which shows their doubt regarding vaccine safety. \hyperref[b13]{14} Worryingly, the exceptionally rapid pace of vaccine development, the skepticism of certain groups of science and health experts might elevate doubt about COVID-19 vaccine. \hyperref[b14]{15} VI. 
\section[{Conclusion}]{Conclusion}\par
The COVID-19 pandemic is still experiencing worldwide disasters and lives, but a possible ray of hope for the future can be found with the COVID-19 vaccine. The findings recommend immediate programs of health education and that the respective health authorities should provide more accurate information. In order to decrease vaccine relief enabled and promoted by disinformation in the media, policymakers should take efforts to provide appropriate understanding, favorable attitudes and views of COVID-19 immunization.\begin{figure}[htbp]
\noindent\textbf{1}\includegraphics[]{image-2.png}
\caption{\label{fig_0}Figure- 1 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{-} \par 
\begin{longtable}{P{0.25796019900497513\textwidth}P{0.2917910447761194\textwidth}P{0.30024875621890545\textwidth}}
\tabcellsep Rural\tabcellsep Urban\\
Age group\tabcellsep Frequency (n=60)\tabcellsep Frequency (n=60)\\
\tabcellsep (\%)\tabcellsep (\%)\\
20-31 years\tabcellsep 13 (21.67)\tabcellsep 06 (10)\\
32-43 years\tabcellsep 23 (38.33)\tabcellsep 16 (26.67)\\
44-55 years\tabcellsep 18 (30)\tabcellsep 31 (51.66)\\
55 above years\tabcellsep 06 (10)\tabcellsep 7 (11.67)\\
Total\tabcellsep 60 (100\%)\tabcellsep 60 (100\%)\end{longtable} \par
 
\caption{\label{tab_1}Table - 1}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{-} \par 
\begin{longtable}{P{0.3736168032786885\textwidth}P{0.06357581967213115\textwidth}P{0.3535860655737705\textwidth}P{0.05922131147540983\textwidth}}
\tabcellsep Rural\tabcellsep \tabcellsep Urban\\
Education\tabcellsep \multicolumn{2}{l}{Frequency (n=60)}\tabcellsep Frequency (n=60)\\
\tabcellsep (\%)\tabcellsep \tabcellsep (\%)\\
Primary\tabcellsep \multicolumn{2}{l}{13 ( 21.7)}\tabcellsep 05 (8.33)\\
SSC\tabcellsep \multicolumn{2}{l}{05 ( 8.33 )}\tabcellsep 12( 20)\\
HSC\tabcellsep 30 ( 50 )\tabcellsep \tabcellsep 25 (41.67)\\
Graduate\tabcellsep 12 ( 20)\tabcellsep \tabcellsep 18 (30)\\
Total\tabcellsep \multicolumn{2}{l}{60 (100\%)}\tabcellsep 60 (100\%)\\
\multicolumn{2}{l}{Table-4 Explores the distribution of the}\tabcellsep \multicolumn{2}{l}{knowledge related factor regarding the lowest age range}\\
\multicolumn{2}{l}{respondents by knowledge related factors and}\tabcellsep \multicolumn{2}{l}{for this vaccination was moderately significant (p=0.03),}\\
\multicolumn{2}{l}{association with gender of rural \& urban area. The}\tabcellsep \multicolumn{2}{l}{finally knowledge related factor regarding the way to}\\
\multicolumn{2}{l}{association of Covid-19 infected status between rural \&}\tabcellsep \multicolumn{2}{l}{take the vaccine was also significantly associated}\\
\multicolumn{2}{l}{urban respondents were highly significant (P= 0.00),}\tabcellsep \multicolumn{2}{l}{(p=0.04) between the respondents of rural \& urban}\\
\multicolumn{2}{l}{similarly knowledge regarding first vaccine in}\tabcellsep \multicolumn{2}{l}{area, beside the knowledge related factors the other}\\
\multicolumn{2}{l}{Bangladesh also highly significant (p=0.02) between}\tabcellsep \multicolumn{2}{l}{variables were not significantly associated. The following}\\
\multicolumn{2}{l}{rural \& urban respondents. Another findings regarding}\tabcellsep \multicolumn{2}{l}{table is given below in detail:}\end{longtable} \par
 
\caption{\label{tab_2}Table - 2}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{-} \par 
\begin{longtable}{P{0.3181497175141243\textwidth}P{0.096045197740113\textwidth}P{0.09244350282485875\textwidth}P{0.15927495291902072\textwidth}P{0.084439736346516\textwidth}P{0.07963747645951036\textwidth}P{0.02000941619585687\textwidth}}
\multicolumn{2}{l}{What is the lowest age range for}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{this vaccination?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep 25 years\tabcellsep 20 (43.47)\tabcellsep 4 (28.57)\tabcellsep 8 (21.05)\tabcellsep 05 (22.72)\tabcellsep 0.03\\
?\tabcellsep 40 years\tabcellsep 26 (56.53)\tabcellsep 10 (71.43)\tabcellsep 30 ( 78.95)\tabcellsep 17 (77.28)\tabcellsep \\
\multicolumn{2}{l}{What is the way to take this}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{vaccine?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep Present directly to the health\tabcellsep 8 (17.39)\tabcellsep 04 (28.57)\tabcellsep 8 (21.06)\tabcellsep 4 (18.18)\tabcellsep \\
\tabcellsep center\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep Firstly, to register on the web\tabcellsep 34 (73.91)\tabcellsep 08 (57.14)\tabcellsep 30 (78.94)\tabcellsep 18 (18.82)\tabcellsep 0.041\\
\tabcellsep website\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep I don't know\tabcellsep 04 (8.70)\tabcellsep 02 (14.29)\tabcellsep 00\tabcellsep 00\tabcellsep \\
\multicolumn{3}{l}{Note: p ? 0.05 considered as significant value}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{3}{l}{Table-5 Find out the distribution of each attitude}\tabcellsep \multicolumn{4}{l}{about corona vaccine also moderately significant}\\
\multicolumn{3}{l}{and practice item and gender of rural \& urban area. The}\tabcellsep \multicolumn{4}{l}{(p=0.03) others attitude and practice related factors}\\
\multicolumn{3}{l}{association of Covid-19 vaccine taken status between}\tabcellsep \multicolumn{4}{l}{were not significantly associated. The following table is}\\
\multicolumn{3}{l}{rural \& urban respondents were highly significant (P=}\tabcellsep \multicolumn{2}{l}{given below in detail:}\tabcellsep \tabcellsep \\
\multicolumn{3}{l}{0.00), similarly the opinion regarding so many rumors}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\tabcellsep \tabcellsep \multicolumn{2}{l}{Rural}\tabcellsep Urban\tabcellsep \tabcellsep \\
\tabcellsep Knowledge items\tabcellsep Male Frequency (n=46) (\%)\tabcellsep Female Frequency (n=14) (\%)\tabcellsep Male Frequency (n=38) (\%)\tabcellsep Female (n=22) (\%)\tabcellsep P value\\
\multicolumn{2}{l}{Have you ever been infected to}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{covid-19?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep Yes\tabcellsep 22 (47.8)\tabcellsep 8 (57.14)\tabcellsep 22 (57.89)\tabcellsep 12 (54.54)\tabcellsep 0.00\\
?\tabcellsep No\tabcellsep 24 (52.2)\tabcellsep 6 (42.86)\tabcellsep 16 (42.11)\tabcellsep 10 (45.46)\tabcellsep \\
\multicolumn{2}{l}{Any of your family member ever got}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{infected to covid-19?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep Yes\tabcellsep 25 (54.35)\tabcellsep 7 (50)\tabcellsep 20 (52.63)\tabcellsep 8 (36.36)\tabcellsep 0.584\\
?\tabcellsep No\tabcellsep 21 (45.65)\tabcellsep 7 (50)\tabcellsep 18 (47.37)\tabcellsep 14 (63.64)\tabcellsep \\
\multicolumn{2}{l}{Do you have any Knowledge of}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{covid-19 vaccination?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep Yes\tabcellsep 38 (80.61)\tabcellsep 10 (71.73)\tabcellsep 34 (89.47)\tabcellsep 19 (86.36)\tabcellsep 0.317\\
?\tabcellsep No\tabcellsep 8 (19.29)\tabcellsep 4 (28.27)\tabcellsep 04 ( 10.53)\tabcellsep 03 ( 13.64)\tabcellsep \\
\multicolumn{2}{l}{When did Bangladesh started}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{corona vaccination?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep January 2021\tabcellsep 33 (71.73)\tabcellsep 8 (57.14)\tabcellsep 30 (78.95)\tabcellsep 18 (81.81)\tabcellsep 0.210\\
?\tabcellsep February 2021\tabcellsep 13 (28.27)\tabcellsep 6 (42.86)\tabcellsep 8 (21.05)\tabcellsep 4 (18.19)\tabcellsep \\
\multicolumn{2}{l}{What is the name of first corona}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{vaccine in Bangladesh?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep COVISHIELD-Oxford\tabcellsep 30 (65.22)\tabcellsep 8 (57.14)\tabcellsep 30 (78.94)\tabcellsep 19 (83.36)\tabcellsep \\
?\tabcellsep Sputnik V-Russia\tabcellsep 6 (13.04)\tabcellsep 3 (21.42)\tabcellsep 8 (21.06)\tabcellsep 3 (16.64)\tabcellsep 0.002\\
?\tabcellsep Pfizer-USA\tabcellsep 8 (17.39)\tabcellsep 2 (14.28)\tabcellsep 00\tabcellsep 00\tabcellsep \\
?\tabcellsep Sinovac-China\tabcellsep 2 (4.33)\tabcellsep 1 (7.16)\tabcellsep 00\tabcellsep 00\tabcellsep \\
\multicolumn{2}{l}{How many corona vaccines dose}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{need to take in this country?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep 1 dose\tabcellsep 5 (10.86)\tabcellsep 4 (28.57)\tabcellsep 3 (7.89)\tabcellsep 4 (18.18)\tabcellsep 0.591\\
?\tabcellsep 2 doses\tabcellsep 41 (89.14)\tabcellsep 10 (71.43)\tabcellsep 35 (92.11)\tabcellsep 18 (81.81)\tabcellsep \\
\multicolumn{2}{l}{After the first dose of vaccination}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{how many days it takes for the}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{second dose?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep 60 days\tabcellsep 40 (86.95)\tabcellsep 12 (85.71)\tabcellsep 35 (92.10)\tabcellsep 22 (91.66)\tabcellsep 0.378\\
?\tabcellsep 45 days\tabcellsep 06 ( 3.05)\tabcellsep 02 (14.29)\tabcellsep 3 (7.90)\tabcellsep 02 (8.34)\tabcellsep \end{longtable} \par
 
\caption{\label{tab_3}Table - 4}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{-} \par 
\begin{longtable}{P{0.312984496124031\textwidth}P{0.01317829457364341\textwidth}P{0.0032945736434108527\textwidth}P{0.003953488372093023\textwidth}P{0.11069767441860465\textwidth}P{0.11003875968992247\textwidth}P{0.14693798449612402\textwidth}P{0.09027131782945737\textwidth}P{0.028333333333333332\textwidth}P{0.030310077519379842\textwidth}}
\multicolumn{4}{l}{Description Have you taken the vaccine? ? Yes ? No Is there any side effect of corona vaccination? ? Yes ? No}\tabcellsep Male n=46 \% 16 (34.78) 30 (65.22) 14 (30.43) 32 (69.57)\tabcellsep Rural 5 (35.71) Female n=14 \% 9 (64.29) 4 (28.57) 10 (71.43)\tabcellsep \multicolumn{2}{l}{Urban 17 (77.27) Female n=22 \% 5 (22.73) 30 (78.95) Male, n=38 \% 25(65.79) 13 (34.21) 8 (21.05) 4 (18.18) 18 (81.82)}\tabcellsep P value 0.00 0.148\tabcellsep Volume XXI Issue III Version I\\
\multicolumn{4}{l}{After taking the vaccine is}\tabcellsep \tabcellsep \tabcellsep \tabcellsep D D D D ) B\\
\multicolumn{4}{l}{there any side effect seen?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep (\\
\multicolumn{4}{l}{? ? ? ? There are so many rumors Fever Body ache Pain in inject area Others about corona vaccine, do you believe those?}\tabcellsep 09 (19.56) 15 (32.61) 20 (43.48) 02 (4.35)\tabcellsep 02 (14.29) 03 (21.43) 08 (57.14) 01 (7.14)\tabcellsep 06 (15.79) 10 (26.32) 22 (57.89) 00\tabcellsep 02 (9.09) 08 (36.36) 12 (54.55) 00\tabcellsep 0.256\tabcellsep Medical Research\\
?\tabcellsep Yes\tabcellsep \tabcellsep \tabcellsep 12 (26.09)\tabcellsep 5 (35.71)\tabcellsep 03 (7.89)\tabcellsep 4 (18.18)\tabcellsep 0.039\\
?\tabcellsep No\tabcellsep \tabcellsep \tabcellsep 34 (73.91)\tabcellsep 9 (64.29)\tabcellsep 35 ( 92.11)\tabcellsep 18 (81.82)\\
\multicolumn{4}{l}{Are you tensed about the side}\tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{4}{l}{effect of corona vaccine?}\tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep Yes\tabcellsep \tabcellsep \tabcellsep 12 (26.09)\tabcellsep 5 (35.71)\tabcellsep 05 (13.16)\tabcellsep 04 (18.18)\tabcellsep 0.120\\
?\tabcellsep No\tabcellsep \tabcellsep \tabcellsep 34 (73.91)\tabcellsep 9 (64.29)\tabcellsep 33 (86.84)\tabcellsep 18 (81.82)\\
\multicolumn{4}{l}{Do you think the related}\tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{4}{l}{person should be more}\tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{concern}\tabcellsep about\tabcellsep corona\tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{2}{l}{vaccine?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep Yes\tabcellsep \tabcellsep \tabcellsep 32 (69.57)\tabcellsep 9 (64.29)\tabcellsep 33 (86.84) 05\tabcellsep 18 (81.82)\tabcellsep 0.119\\
?\tabcellsep No\tabcellsep \tabcellsep \tabcellsep 14 (30.43)\tabcellsep 5 (35.71)\tabcellsep (13.16)\tabcellsep 04 (22.73)\\
\multicolumn{4}{l}{Would you share the right}\tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{4}{l}{information to your family}\tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{3}{l}{friends and society?}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
?\tabcellsep Yes\tabcellsep \tabcellsep \tabcellsep 46 (100)\tabcellsep 14 (100)\tabcellsep 38 (100)\tabcellsep 22 (100)\tabcellsep 0.163\\
?\tabcellsep No\tabcellsep \tabcellsep \tabcellsep 00\tabcellsep 00\tabcellsep 00\tabcellsep 00\\
\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep © 2021 Global Journals\end{longtable} \par
  {\small\itshape [Note: Note: p ? 0.05 considered as significant value]} 
\caption{\label{tab_4}Table - 5}\end{figure}
 		 		\backmatter  			  				\begin{bibitemlist}{1}
\bibitem[Reiter et al. ()]{b2}\label{b2} 	 		‘Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?’.  		 			P L Reiter 		,  		 			M L Pennell 		,  		 			M L Katz 		.  		 doi: 10.1016/j. vaccine.2020.08.043.  	 	 		\textit{Vaccine}  		2020. 38 p. .  	 
\bibitem[Wang et al. ()]{b13}\label{b13} 	 		‘Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China’.  		 			J Wang 		,  		 			R Jing 		,  		 			X Lai 		,  		 			H Zhang 		,  		 			Y Lyu 		,  		 			M D Knoll 		.  		 \xref{http://dx.doi.org/10.3390/vaccines8030482}{10.3390/vaccines8030482}.  	 	 		\textit{Vaccines}  		2020. 8 p. 482.  	 
\bibitem[Rahman et al. ()]{b9}\label{b9} 	 		‘Assessment of knowledge, attitudes and practices towards prevention of coronavirus disease (COVID-19) among Bangladeshi population’.  		 			Smm Rahman 		,  		 			A Akter 		,  		 			K F Mostari 		,  		 			S Ferdousi 		,  		 			I J Ummon 		,  		 			S M Naafi 		.  		 doi:10.3329/ bmrcb.v46i2.49015.  	 	 		\textit{Bangladesh Med Res Counc Bull}  		2020. 46 p. .  	 
\bibitem[Daily (2021)]{b4}\label{b4} 	 		\textit{Bharat Biotech's Coronavirus Vaccine: Concerns grow in India over safety},  		 			The Daily 		,  		 			Star 		.  		 \url{https://www.thedailystar.net/frontpage/news/bharat-biotechs-coronavirus-vaccine-concerns-grow-india-over-safety-2028549}  		2021. 10 Feb 2021.  	 
\bibitem[Chou and Budenz ()]{b14}\label{b14} 	 		‘Considering emotion in COVID-19 vaccine communication: Addressing vaccine hesitancy and fostering vaccine confidence’.  		 			W-Ys Chou 		,  		 			A Budenz 		.  		 doi:10.1080/ 10410236.2020.1838096.  	 	 		\textit{Health Commun}  		2020. 35 p. .  	 
\bibitem[Callaghan et al. ()]{b12}\label{b12} 	 		‘Correlates and Disparities of COVID-19 Vaccine Hesitancy’.  		 			T Callaghan 		,  		 			A Moghtaderi 		,  		 			J Lueck 		,  		 			P Hotez 		,  		 			U Strych 		,  		 			A Dor 		.  		 \xref{http://dx.doi.org/10.2139/ssrn.3667971}{10.2139/ssrn.3667971}.  	 	 		\textit{SSRN Electron J}  		2020.  	 
\bibitem[Wibawa ()]{b1}\label{b1} 	 		‘COVID-19 vaccine research and development: ethical issues’.  		 			T Wibawa 		.  		 \xref{http://dx.doi.org/10.1111/tmi.13503}{10.1111/tmi.13503}.  	 	 		\textit{Trop Med Int Heal}  		2021. 26 p. .  	 
\bibitem[Mirowsky and Ross ()]{b10}\label{b10} 	 		‘Education, personal control, lifestyle and health: A human capital hypothesis’.  		 			J Mirowsky 		,  		 			C E Ross 		.  		 doi:10.1177/ 0164027598204003.  	 	 		\textit{Res Aging}  		1998. 20 p. .  	 
\bibitem[Lazarus et al. ()]{b5}\label{b5} 	 		\textit{Hesitant or not? A global survey of potential acceptance of a COVID-19 vaccine. medRxiv},  		 			J V Lazarus 		,  		 			S Ratzan 		,  		 			A Palayew 		,  		 			L O Gostin 		,  		 			H J Larson 		,  		 			K Rabin 		.  		 \xref{http://dx.doi.org/10.1101/2020.08.23.20180307}{10.1101/2020.08.23.20180307}.  		2020.  	 
\bibitem[Islam et al.]{b7}\label{b7} 	 		‘Knowledge, attitudes and practices associated with the COVID-19 among slum dwellers resided in Dhaka City: a Bangladeshi interviewbased survey’.  		 			M S Islam 		,  		 			G I Emran 		,  		 			E Rahman 		,  		 			R Banik 		,  		 			T Sikder 		,  		 			L Smith 		.  		 \xref{http://dx.doi.org/10.1093/pubmed/fdaa182}{10.1093/pubmed/fdaa182}.  	 	 		\textit{J Public Health}  		p. 2020.  	 
\bibitem[Islam et al.]{b8}\label{b8} 	 		‘Knowledge, attitudes and practices associated with the COVID-19 among slum dwellers resided in Dhaka City: a Bangladeshi interviewbased survey’.  		 			M S Islam 		,  		 			G I Emran 		,  		 			E Rahman 		,  		 			R Banik 		,  		 			T Sikder 		,  		 			L Smith 		.  		 \xref{http://dx.doi.org/10.1093/pubmed/fdaa182}{10.1093/pubmed/fdaa182}.  	 	 		\textit{J Public Health}  		p. 2020.  	 
\bibitem[Hossain et al. ()]{b6}\label{b6} 	 		‘Knowledge, attitudes, and fear of COVID-19 during the Rapid Rise Period in Bangladesh’.  		 			M A Hossain 		,  		 			Mik Jahid 		,  		 			Kma Hossain 		,  		 			L M Walton 		,  		 			Z Uddin 		,  		 			M O Haque 		.  		 \xref{http://dx.doi.org/10.1371/journal.pone.0239646}{10.1371/journal.pone.0239646}.  	 	 		\textit{PLoS One}  		2020. 15 p. e0239646.  	 
\bibitem[Tribune ()]{b3}\label{b3} 	 		\textit{Nurse Runu becomes Bangladesh's first COVID-19 vaccine recipient},  		 			Dhaka Tribune 		.  		2020.  	 	 (cited 10 Feb) 
\bibitem[Nguyen et al. ()]{b11}\label{b11} 	 		‘Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study’.  		 			L H Nguyen 		,  		 			D A Drew 		,  		 			M S Graham 		,  		 			A D Joshi 		,  		 			C-G Guo 		,  		 			W Ma 		.  		 \xref{http://dx.doi.org/10.1016/S2468-2667(20)30164-X}{10.1016/S2468-2667(20)30164-X}.  	 	 		\textit{Lancet Public Heal}  		2020. 5 p. .  	 
\bibitem[Chan et al. ()]{b0}\label{b0} 	 		‘Willingness of future A/H7N9 influenza vaccine uptake: A cross-sectional study of Hong Kong community’.  		 			Ey-Y Chan 		,  		 			Ck-Y Cheng 		,  		 			Gc-H Tam 		,  		 			Z Huang 		,  		 			P Y Lee 		.  		 \xref{http://dx.doi.org/10.1016/j.vaccine.2015.07.046}{10.1016/j.vaccine.2015.07.046}.  	 	 		\textit{Vaccine}  		2015. 33 p. .  	 
\end{bibitemlist}
 			 		 	 
\end{document}
